000 | 01789 a2200553 4500 | ||
---|---|---|---|
005 | 20250516034142.0 | ||
264 | 0 | _c20120105 | |
008 | 201201s 0 0 eng d | ||
022 | _a1523-1755 | ||
024 | 7 |
_a10.1038/ki.2011.117 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBonomini, Mario | |
245 | 0 | 0 |
_aL-carnitine is an osmotic agent suitable for peritoneal dialysis. _h[electronic resource] |
260 |
_bKidney international _cSep 2011 |
||
300 |
_a645-54 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAquaporin 1 _xdeficiency |
650 | 0 | 4 |
_aCarnitine _xpharmacokinetics |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aDialysis Solutions _xpharmacology |
650 | 0 | 4 |
_aGlucose _xpharmacology |
650 | 0 | 4 | _aHuman Umbilical Vein Endothelial Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aOsmosis _xdrug effects |
650 | 0 | 4 |
_aPeritoneal Dialysis _xmethods |
650 | 0 | 4 |
_aPeritoneum _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aUltrafiltration _xmethods |
700 | 1 | _aPandolfi, Assunta | |
700 | 1 | _aDi Liberato, Lorenzo | |
700 | 1 | _aDi Silvestre, Sara | |
700 | 1 | _aCnops, Yvette | |
700 | 1 | _aDi Tomo, Pamela | |
700 | 1 | _aD'Arezzo, Mario | |
700 | 1 | _aMonaco, Maria P | |
700 | 1 | _aGiardinelli, Annalisa | |
700 | 1 | _aDi Pietro, Natalia | |
700 | 1 | _aDevuyst, Olivier | |
700 | 1 | _aArduini, Arduino | |
773 | 0 |
_tKidney international _gvol. 80 _gno. 6 _gp. 645-54 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/ki.2011.117 _zAvailable from publisher's website |
999 |
_c20790516 _d20790516 |